Bone turnover markers in Spanish adult men. The Camargo Cohort Study

Clinica Chimica Acta

Volumn 411, Issue 19-20, 2010, Pages 1511-1515

  Olmos, José M ^a   Hernández, José L ^a   Martínez, Josefina ^a   Pariente, Emilio ^b   Llorca, Javier ^b   González Macías, Jesús ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

25 Hydroxyvitamin D; Bone mineral density; Bone turnover markers; Men; Parathyroid hormone

Indexed keywords

25 HYDROXYVITAMIN D; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; COLLAGEN TYPE 1 AMINOPROPEPTIDE; PARATHYROID HORMONE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOANALYZER; BONE DENSITY; BONE TURNOVER; COMMUNITY SAMPLE; CONTROLLED STUDY; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; HIP; HUMAN; LUMBAR SPINE; MALE; NORMAL VALUE; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SPAIN; VITAMIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; BONE REMODELING; COHORT STUDIES; COLLAGEN TYPE I; CROSS-SECTIONAL STUDIES; FETAL PROTEINS; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PROCOLLAGEN; REFERENCE VALUES; SPAIN; VITAMIN D;

EID: 77955056392     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.06.010     Document Type: Article

References (25)

1. Ebeling P.R. Clinical practice. Osteoporosis in men. N Engl J Med 2008, 358:1474-1482.
2. Fransen M., Woodward M., Norton R., Robinson E., Butler M., Campbell A.J. Excess mortality or institutionalisation after hip fracture: men greater risk than women. J Am Geriatr Soc 2002, 50:685-690.
3. Nguyen N.D., Pongchaikayul C., Center J.R., Eisman J.A., Nguyen T.V. Identification of high-risk individuals for hip fracture: a 14-year prospective study. J Bone Miner Res 2005, 20:1921-1928.
4. Garnero P., Hauser E., Chapuy M.C., et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 1996, 11:1531-1538.
5. Sarkar S., Reginster J.Y., Crans G.G., Díez-Pérez A., Pinette K.V., Delmas P. Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk. J Bone Miner Res 2004, 19:394-401.
6. Szulc P., Kaufman J.M., Delmas P.D. Biochemical assessment of bone turnover and bone fragility in men. Osteoporos Int 2007, 18:1451-1461.
7. Bauer D.C., Garnero P., Harrison S.L., et al. Biochemical Markers of bone turnover, hip bone loss, and fracture in older men: the MrOs study. J Bone Miner Res 2009, 24:2032-2038.
8. Meier C., Seibel M.J., Kraenzlin M.E. Use of bone turnover markers in the real world: are we there yet?. J Bone Miner Res 2009, 24:386-388.
9. Srivastava A.K., Vilet E.L., Lewiecki E.M., et al. Clinical use of serum and urine bone markers in the management of osteoporosis. Curr Med Res Opin 2005, 21:1015-1026.
10. Martínez J., Olmos J.M., Hernández J.L., et al. Bone turnover markers in Spanish postmenopausal women. The Camargo Cohort Study. Clin Chim Acta 2009, 409:70-74.
11. Olmos J.M., Hernández J.L., Martínez J., et al. Bone turnover markers and bone mineral density in hypertensive postmenopausal women on treatment. Maturitas 2010, 65:396-402.
12. Berry E.M., Gupta M.M., Turner S.J., Burns R.R. Variations in plasma calcium with induced changes in plasma specific gravity, total protein, and albumin. Br Med J 1973, IV:640-643.
13. Garnero P., Vergnaud P., Hoyle N. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem 2008, 54:188-196.
14. Garnero P., Borel O., Delmas P.D. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem 2001, 47:694-702.
15. Schmidt-Gayk H., Spanuth E., Kotting J., et al. Performance evaluation of automated assays for β-crosslaps, N-MID-osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study). Clin Chem Lab Med 2004, 42:90-95.
16. Looker A.C., Orwoll E.S., Johnston C.C., et al. Prevalence of low femoral bone density in oldr U.S. adults from NHANES III. J Bone Miner Res 1997, 12:1761-1768.
17. Riancho J.A., Valero C., Hernández J.L., et al. Biomechanical indices of the femoral neck estimated from the Standard DXA output: age- and sex-related differences. J Clin Densitom 2007, 10:39-45.
18. Chen J.S., Cameron I.A., Cumming R.G., et al. Effect of age-related chronic immobility on markers of bone turnover. J Bone Miner Res 2006, 21:324-331.
19. Glover S.J., Gall M., Schoenborn-Kellenberg O., et al. Establishing a reference interval for bone turnover marker in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Miner Res 2009, 24:389-397.
20. Szulc P., Delmas P.D. Biochemical markers of bone turnover in men. Calcif Tissue Int 2001, 69:229-234.
21. Fatayeri D., Eastell R. Age-related changes in bone turnover in men. J Bone Miner Res 1999, 14:1203-1210.
22. Minisola S., Dionisi S., Pacitti M.T., et al. Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone. Osteoporos Int 2002, 13:171-175.
23. Szulc P., Maurice C., Marchand F., Delmas P.D. Increased bone resorption is associated with high mortality in community-dwelling men>50 years of age: the MINOS study. J Bone Miner Res 2009, 24:1116-1124.
24. Meier C., Nguyen T.V., Center J.R., Seibel M.J., Eisman J.A. Bone resorption and osteoporotic fractures in elderly men: the Dubbo osteoporosis epidemiology study. J Bone Miner Res 2005, 20:579-587.
25. NCCLS Application of biochemical markers of bone turnover in the assessment and monitoring of bone disease. Proposed Guidelines 2004, NCCLS document C48-P.